Engineering DNA vaccines via co-delivery of co-stimulatory molecule genesKIM, J. J; NOTTINGHAM, L. K; WILSON, D. M et al.Vaccine. 1998, Vol 16, Num 19, pp 1828-1835, issn 0264-410XConference Paper

Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal siteWANG, B; DANG, K; AGADJANYAN, M. G et al.Vaccine. 1997, Vol 15, Num 8, pp 821-825, issn 0264-410XConference Paper

DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1AGADJANYAN, M. G; WANG, B; NYLAND, S. B et al.Current Topics in Microbiology and Immunology. 1998, Vol 226, pp 175-192, issn 0070-217XArticle

Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein : HIV-1 expression is permissive for HTLV-II-induced cell fusionBIN WANG; AGADJANYAN, M. G; VASANTHA SRIKANTAN et al.AIDS research and human retroviruses. 1993, Vol 9, Num 9, pp 849-860, issn 0889-2229Article

DNA, but not protein vaccine based on mutated BORIS antigen significantly inhibits tumor growth and prolongs the survival of miceMKRTICHYAN, M; GHOCHIKYAN, A; LOUKINOV, D et al.Gene therapy (Basingstoke). 2008, Vol 15, Num 1, pp 61-64, issn 0969-7128, 4 p.Article

Monoclonal antibodies define a cellular antigen involved in HTLV-I infectionAGADJANYAN, M. G; CHATTERGOON, M. A; PETRUSHINA, I et al.Hybridoma. 1998, Vol 17, Num 1, pp 9-19, issn 0272-457XArticle

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genesKIM, J. J; BAGARAZZI, M. L; CHALIAN, A. A et al.Nature biotechnology. 1997, Vol 15, Num 7, pp 641-646, issn 1087-0156Article

DNA prime―protein boost increased the titer, avidity and persistence of anti-Aβ antibodies in wild-type miceDAVTYAN, H; MKRTICHYAN, M; MOVSESYAN, N et al.Gene therapy (Basingstoke). 2010, Vol 17, Num 2, pp 261-271, issn 0969-7128, 11 p.Article

Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivoKIM, J. J; YANG, J.-S; AGADJANYAN, M. G et al.Human gene therapy. 2000, Vol 11, Num 2, pp 305-321, issn 1043-0342Article

An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIVAGADJANYAN, M. G; TRIVEDI, N. N; WEINER, D. B et al.AIDS research and human retroviruses. 1997, Vol 13, Num 18, pp 1561-1572, issn 0889-2229Article

Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1 : Prelude to a clinical trialUGEN, K. E; BOYER, J. D; CONEY, L et al.Vaccine. 1997, Vol 15, Num 8, pp 927-930, issn 0264-410XConference Paper

Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type 1 and type II syncytium formation and infectionAGADJANYAN, M. G; UGEN, K. E; BIN WANG et al.Journal of virology. 1994, Vol 68, Num 1, pp 485-493, issn 0022-538XArticle